Table 3.
COVID-19 vaccination status of the study participants stratified according to diseases status and severity.
| Vaccination status/Vaccine regimen | Cases/Disease severity | ||||
|---|---|---|---|---|---|
| Asymptomatic | Mild | Moderate | Severe | Critical | |
| Unvaccinated | 12 | 99 | 44 | 28 | 24 |
| 2 doses | |||||
| CoronaVac-CoronaVac | 9 | 163 | 30 | 1 | 1 |
| ChAdOx1-ChAdOx1 | 26 | 492 | 65 | 21 | 4 |
| BNT162b2-BNT162b2 | 3 | 121 | 12 | 2 | 1 |
| 3 doses | |||||
| CoronaVac-CoronaVac-BNT162b2 | 12 | 279 | 16 | 1 | 0 |
| ChAdOx1- ChAdOx1-BNT162b2 | 23 | 553 | 78 | 16 | 4 |
| CoronaVac-CoronaVac-ChAdOx1 | 4 | 159 | 14 | 2 | 1 |
| 4 doses | |||||
| CoronaVac-CoronaVac-BNT162b2-BNT162b2 | 6 | 193 | 19 | 0 | 0 |
| CoronaVac-CoronaVac-ChAdOx1-BNT162b2 | 5 | 154 | 9 | 0 | 0 |